Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.2 USD | -0.59% |
|
+8.53% | +40.04% |
05-20 | Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing | MT |
05-17 | Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.04% | 54.04B | |
+43.57% | 41.96B | |
-1.18% | 41.92B | |
-7.59% | 28.35B | |
+12.55% | 26.35B | |
-22.17% | 19B | |
+7.87% | 13B | |
+28.37% | 12.28B | |
+25.17% | 12.19B | |
-6.42% | 11.49B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Goldman Sachs Adjusts Price Target on Moderna to $204 From $206